| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 8.630 | 20.735 | 25.665 | 25.706 | 27.048 | 51.396 | 44.305 | 48.958 | 54.077 |
| Total Income - EUR | 0 | 8.630 | 20.736 | 27.130 | 27.512 | 27.751 | 51.587 | 45.300 | 48.959 | 57.380 |
| Total Expenses - EUR | 0 | 8.220 | 16.968 | 28.728 | 26.248 | 22.476 | 25.901 | 23.808 | 36.440 | 54.651 |
| Gross Profit/Loss - EUR | 0 | 410 | 3.768 | -1.598 | 1.264 | 5.274 | 25.686 | 21.492 | 12.519 | 2.730 |
| Net Profit/Loss - EUR | 0 | 237 | 3.195 | -1.855 | 1.007 | 5.144 | 25.235 | 21.048 | 12.029 | 1.107 |
| Employees | 0 | 1 | 1 | 3 | 3 | 2 | 2 | 2 | 2 | 1 |
Check the financial reports for the company - T&A Med Consulting Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 2.334 | 6.704 | 9.292 | 7.080 | 4.953 | 7.019 | 6.349 | 42.148 | 35.128 |
| Current Assets | 1.398 | 3.178 | 14.181 | 10.300 | 10.405 | 15.269 | 32.160 | 23.986 | 14.302 | 6.216 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 |
| Receivables | 1.398 | 2.738 | 1.480 | 2.205 | 3.269 | 1.666 | 6.001 | 2.901 | 6.516 | 948 |
| Cash | 0 | 441 | 12.702 | 8.095 | 7.136 | 13.603 | 26.158 | 21.085 | 7.786 | 5.260 |
| Shareholders Funds | 1.014 | 1.241 | 4.415 | 2.479 | 3.439 | 8.517 | 27.903 | 21.460 | 33.424 | 31.067 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 384 | 4.272 | 16.470 | 17.112 | 14.046 | 11.705 | 11.276 | 8.875 | 23.026 | 10.277 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - T&A Med Consulting Srl